Urszula Oleksiewicz

9PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 10, 2026
Circulating Tumor Cells for the Monitoring of Lung Cancer Therapies.

Maja Chrzempiec, Urszula Oleksiewicz

|Nov 09, 2024
The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy.

Urszula Oleksiewicz, Monika Kuciak, Anna Jaworska

|Jul 27, 2024
The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors.

Kacper Maciejewski, Marek Giers, Urszula Oleksiewicz

|Nov 25, 2023
ZNF643/ZFP69B Exerts Oncogenic Properties and Associates with Cell Adhesion and Immune Processes.

Urszula Oleksiewicz, Marta Machnik, Joanna Sobocińska

|Nov 14, 2023
ZNF714 Supports Pro-Oncogenic Features in Lung Cancer Cells.

Urszula Oleksiewicz, Marta Machnik, Joanna Sobocińska

|Aug 27, 2021
Disruption of RING and PHD Domains of TRIM28 Evokes Differentiation in Human iPSCs.

Sylwia Mazurek, Urszula Oleksiewicz, Patrycja Czerwińska

Pageof 2